Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
rolinsatamab talirine (ABBV-176)
i
Other names:
ABBV-176, ABBV 176
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
AbbVie
Drug class:
DNA cross linking agent, Prolactin receptor-targeted antibody-drug conjugate
Related drugs:
‹
oxaliplatin (57)
idarubicin hydrochloride (16)
INT230-6 (1)
BP-C1 (0)
BTP-114 (0)
cisplatin liposomal (0)
miriplatin (0)
mitomycin (0)
demplatin pegraglumer (0)
AP 5346 (0)
apaziquone (0)
SG 2000 (0)
AS-1-145 (0)
oxaliplatin (57)
idarubicin hydrochloride (16)
INT230-6 (1)
BP-C1 (0)
BTP-114 (0)
cisplatin liposomal (0)
miriplatin (0)
mitomycin (0)
demplatin pegraglumer (0)
AP 5346 (0)
apaziquone (0)
SG 2000 (0)
AS-1-145 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
PRLR underexpression
Breast Cancer
PRLR underexpression
Breast Cancer
ABBV-176
Sensitive: D – Preclinical
ABBV-176
Sensitive
:
D
ABBV-176
Sensitive: D – Preclinical
ABBV-176
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login